These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6190361)

  • 1. Modulation of in vivo nigral 5HT release in the cat.
    Reisine TD; Soubrie P; Bourgoin S; Artaud F; Glowinski J
    Adv Biochem Psychopharmacol; 1983; 36():91-101. PubMed ID: 6190361
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique.
    Soubrié P; Reisine TD; Glowinski J
    Neuroscience; 1984 Nov; 13(3):605-25. PubMed ID: 6084828
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
    Soubrie P; Blas C; Ferron A; Glowinski J
    J Pharmacol Exp Ther; 1983 Aug; 226(2):526-32. PubMed ID: 6410048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H]serotonin release in the basal ganglia of the cat.
    Reisine T; Soubrie P; Artaud F; Glowinski J
    Brain Res; 1982 Mar; 236(2):317-27. PubMed ID: 6175381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra.
    Soubrié P; Montsatruc JL; Bourgoin S; Reisine T; Artaud F; Glowinski J
    Eur J Pharmacol; 1981 Feb; 69(4):483-8. PubMed ID: 6166484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo evidence for acetylcholine control of serotonin release in the cat caudate nucleus: influence of halothane anaesthesia.
    Becquet D; Faudon M; Hery F
    Neuroscience; 1988 Dec; 27(3):819-26. PubMed ID: 3252174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some neuroactive compounds in the substantia nigra.
    Krnjević K
    Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate, glutamate and GABA levels in pallidum, substantia nigra, center median and dorsal raphe nuclei after cylindric lesion of caudate nucleus in cat.
    Taniyama K; Nitsch C; Wagner A; Hassler R
    Neurosci Lett; 1980 Feb; 16(2):155-60. PubMed ID: 6133240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological evidence for the existence of excitatory fibres in the caudato-nigral pathway in the cat.
    Kanazawa I; Yoshida M
    Neurosci Lett; 1980 Dec; 20(3):301-6. PubMed ID: 6160432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of release processes in central serotoninergic neurons.
    Héry F; Ternaux JP
    J Physiol (Paris); 1981; 77(2-3):287-301. PubMed ID: 6457140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nigrostriatal system as a source of torsion extrapyramidal disorders (review)].
    Arushanian EB; Dutov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):930-8. PubMed ID: 6774537
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo presynaptic control of dopamine release in the cat caudate nucleus--III. Further evidence for the implication of corticostriatal glutamatergic neurons.
    Romo R; Chéramy A; Godeheu G; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1091-9. PubMed ID: 2881228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic projection from the ventral tegmental area and substantia nigra to the periaqueductal gray region and the dorsal raphe nucleus.
    Kirouac GJ; Li S; Mabrouk G
    J Comp Neurol; 2004 Feb; 469(2):170-84. PubMed ID: 14694532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of 5-HT release in the caudate nucleus and the substantia nigra of the cat.
    Bourgoin S; Soubrié P; Artaud F; Reisine TD; Glowinski J
    J Physiol (Paris); 1981; 77(2-3):303-7. PubMed ID: 7288646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.